UPDATE 1-EMA committee conditionally approves AbbVie leukaemia drug

Comments Off on UPDATE 1-EMA committee conditionally approves AbbVie leukaemia drug

Oct 14 (Reuters) – AbbVie Inc won the conditional
backing of an advisory committee of the European Medicines
Agency (EMA) on Friday for a drug to treat a form of blood
cancer.

The post UPDATE 1-EMA committee conditionally approves AbbVie leukaemia drug appeared first on NASDAQ.

Reuters: Market News

Related Posts

Create Account



Log In Your Account